Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune complexes in the rheumatic diseases.

R P Kimberly1

  • 1Cornell University Medical College, New York, New York.

Rheumatic Diseases Clinics of North America
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.

Genes and immunity·2015
Same author

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.

Genes and immunity·2014
Same author

GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.

Genes and immunity·2014
Same author

A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus.

Genes and immunity·2012
Same author

Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis.

Genes and immunity·2011
Same author

The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed.

Genes and immunity·2011
Same journal

Bridging the Divide in Global Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Foreword.

Rheumatic diseases clinics of North America·2026
Same journal

Pulmonary Complications of Biological Therapies in Inflammatory and Autoimmune Diseases.

Rheumatic diseases clinics of North America·2026
Same journal

Artificial Intelligence and Social Determinants of Health.

Rheumatic diseases clinics of North America·2026
Same journal

Updates in Ultrasound in Rheumatology.

Rheumatic diseases clinics of North America·2026
Same journal

Health Systems Strengthening to Promote Access to Care for Rheumatic and Musculoskeletal Diseases Globally.

Rheumatic diseases clinics of North America·2026
See all related articles

This review explores how immune complex characteristics influence tissue deposition and clearance. It examines complement receptor (CR1) and Fc receptor interactions, highlighting their role in rheumatic disease pathogenesis.

Area of Science:

  • Immunology
  • Rheumatology
  • Pathogenesis

Background:

  • Immune complexes are crucial in immune responses but can cause disease.
  • Their deposition in tissues is a key factor in pathogenesis.
  • Understanding immune complex handling is vital for disease management.

Purpose of the Study:

  • To review intrinsic properties of immune complexes affecting tissue deposition.
  • To discuss receptor-mediated immune complex clearance mechanisms.
  • To explore the role of complement receptor (CR1) and Fc receptor pathways in disease.

Main Methods:

  • Literature review of immune complex characteristics.
  • Analysis of receptor-mediated clearance mechanisms.
  • Discussion of pathogenetic links in rheumatic diseases.

Related Experiment Videos

Main Results:

  • Intrinsic properties dictate immune complex tissue deposition.
  • Two main receptor systems (CR1 and Fc receptors) handle immune complexes.
  • Abnormalities in these systems contribute to immune complex-mediated diseases.

Conclusions:

  • Immune complex characteristics and handling mechanisms are critical in pathogenesis.
  • Dysfunctional complement and Fc receptor pathways are implicated in rheumatic diseases.
  • Further research into these interactions can inform therapeutic strategies.